REGENERON PHARMACEUTICALS, INC. Investment Income, Nonoperating
REGENERON PHARMACEUTICALS, INC. (REGN) reported Investment Income, Nonoperating of $3.30 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-04.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNonoperating · last filed 2016-11-04
- REGENERON PHARMACEUTICALS, INC. investment income, nonoperating for the quarter ending 2016-09-30 was $3.30M, a 54.25% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. investment income, nonoperating for the quarter ending 2016-06-30 was $2.80M, a 69.45% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. investment income, nonoperating for the quarter ending 2016-03-31 was $2.25M, a 1149.44% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. investment income, nonoperating for the quarter ending 2015-09-30 was $2.14M.
- REGENERON PHARMACEUTICALS, INC. investment income, nonoperating for fiscal 2013 was -$231.00K, a 111.48% decline from fiscal 2012.
- REGENERON PHARMACEUTICALS, INC. investment income, nonoperating for fiscal 2012 was $2.01M, a 43.31% decline from fiscal 2011.
- REGENERON PHARMACEUTICALS, INC. investment income, nonoperating for fiscal 2011 was $3.55M, a 67.25% increase from fiscal 2010.
- REGENERON PHARMACEUTICALS, INC. investment income, nonoperating for fiscal 2010 was $2.12M, a 52.72% decline from fiscal 2009.
| Period end | Investment Income, Nonoperating 3 month | Investment Income, Nonoperating 6 month | Investment Income, Nonoperating 9 month | Investment Income, Nonoperating 12 month |
|---|---|---|---|---|
| 2016-09-30 | $3.30M 10-Q · filed 2016-11-04 | $6.10M derived: sum of 2 quarters · filed 2016-11-04 | $8.35M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $2.80M 10-Q · filed 2016-08-04 | $5.05M 10-Q · filed 2016-08-04 | ||
| 2016-03-31 | $2.25M 10-Q · filed 2016-05-05 | |||
| 2015-09-30 | $2.14M 10-Q · filed 2016-11-04 | $3.79M derived: sum of 2 quarters · filed 2016-11-04 | $3.97M 10-Q · filed 2016-11-04 | |
| 2015-06-30 | $1.65M 10-Q · filed 2016-08-04 | $1.83M 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | $180.00K 10-Q · filed 2016-05-05 | |||
| 2014-06-30 | $1.68M 10-Q · filed 2014-08-05 | $2.61M 10-Q · filed 2014-08-05 | $355.00K derived: sum of 3 quarters · filed 2014-08-05 | $973.00K derived: sum of 4 quarters · filed 2014-08-05 |
| 2014-03-31 | $937.00K 10-Q · filed 2014-05-08 | -$1.32M derived: sum of 2 quarters · filed 2014-05-08 | -$704.00K derived: sum of 3 quarters · filed 2014-05-08 | $250.00K derived: sum of 4 quarters · filed 2014-08-05 |
| 2013-12-31 | -$2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | -$1.64M derived: sum of 2 quarters · filed 2014-02-13 | -$687.00K derived: sum of 3 quarters · filed 2014-08-05 | -$231.00K 10-K · filed 2014-02-13 |
| 2013-09-30 | $618.00K 10-Q · filed 2013-11-05 | $1.57M derived: sum of 2 quarters · filed 2014-08-05 | $2.03M 10-Q · filed 2013-11-05 | $2.41M derived: sum of 4 quarters · filed 2014-08-05 |
| 2013-06-30 | $954.00K 10-Q · filed 2014-08-05 | $1.41M 10-Q · filed 2014-08-05 | $1.79M derived: sum of 3 quarters · filed 2014-08-05 | $2.31M derived: sum of 4 quarters · filed 2014-08-05 |
| 2013-03-31 | $456.00K 10-Q · filed 2014-05-08 | $840.00K derived: sum of 2 quarters · filed 2014-05-08 | $1.36M derived: sum of 3 quarters · filed 2014-05-08 | $1.86M derived: sum of 4 quarters · filed 2014-05-08 |
| 2012-12-31 | $384.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | $901.00K derived: sum of 2 quarters · filed 2014-02-13 | $1.40M derived: sum of 3 quarters · filed 2014-02-13 | $2.01M 10-K · filed 2014-02-13 |
| 2012-09-30 | $517.00K 10-Q · filed 2013-11-05 | $1.02M derived: sum of 2 quarters · filed 2013-11-05 | $1.63M 10-Q · filed 2013-11-05 | $2.43M derived: sum of 4 quarters · filed 2014-02-13 |
| 2012-06-30 | $501.00K 10-Q · filed 2013-08-06 | $1.11M 10-Q · filed 2013-08-06 | $1.91M derived: sum of 3 quarters · filed 2014-02-13 | $2.63M derived: sum of 4 quarters · filed 2014-02-13 |
| 2012-03-31 | $610.00K 10-Q · filed 2013-05-03 | $1.41M derived: sum of 2 quarters · filed 2014-02-13 | $2.12M derived: sum of 3 quarters · filed 2014-02-13 | $3.12M derived: sum of 4 quarters · filed 2014-02-13 |
| 2011-12-31 | $799.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | $1.51M derived: sum of 2 quarters · filed 2014-02-13 | $2.51M derived: sum of 3 quarters · filed 2014-02-13 | $3.55M 10-K · filed 2014-02-13 |
| 2011-09-30 | $715.00K 10-Q · filed 2012-10-24 | $1.71M derived: sum of 2 quarters · filed 2012-10-24 | $2.75M 10-Q · filed 2012-10-24 | $3.39M derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-06-30 | $998.00K 10-Q · filed 2012-07-25 | $2.04M 10-Q · filed 2012-07-25 | $2.67M derived: sum of 3 quarters · filed 2013-02-15 | $3.13M derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-03-31 | $1.04M 10-Q · filed 2012-04-26 | $1.68M derived: sum of 2 quarters · filed 2013-02-15 | $2.13M derived: sum of 3 quarters · filed 2013-02-15 | $2.72M derived: sum of 4 quarters · filed 2013-02-15 |
| 2010-12-31 | $638.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $1.09M derived: sum of 2 quarters · filed 2013-02-15 | $1.68M derived: sum of 3 quarters · filed 2013-02-15 | $2.12M 10-K · filed 2013-02-15 |
| 2010-09-30 | $453.00K 10-Q · filed 2011-10-27 | $1.04M derived: sum of 2 quarters · filed 2011-10-27 | $1.48M 10-Q · filed 2011-10-27 | $2.04M derived: sum of 4 quarters · filed 2012-02-21 |
| 2010-06-30 | $592.00K 10-Q · filed 2011-07-28 | $1.03M 10-Q · filed 2011-07-28 | $1.58M derived: sum of 3 quarters · filed 2012-02-21 | $2.44M derived: sum of 4 quarters · filed 2012-02-21 |
| 2010-03-31 | $439.00K 10-Q · filed 2011-05-03 | $992.00K derived: sum of 2 quarters · filed 2012-02-21 | $1.85M derived: sum of 3 quarters · filed 2012-02-21 | $3.18M derived: sum of 4 quarters · filed 2012-02-21 |
| 2009-12-31 | $553.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | $1.41M derived: sum of 2 quarters · filed 2012-02-21 | $2.74M derived: sum of 3 quarters · filed 2012-02-21 | $4.49M 10-K · filed 2012-02-21 |
| 2009-09-30 | $857.00K 10-Q · filed 2010-10-28 | $2.19M derived: sum of 2 quarters · filed 2010-10-28 | $3.94M 10-Q · filed 2010-10-28 | |
| 2009-06-30 | $1.33M 10-Q · filed 2010-07-28 | $3.08M 10-Q · filed 2010-07-28 | ||
| 2008-12-31 | $18.16M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |